Top Markets
Coin of the day
Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA
Classement en actions #35931
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Prix de l'action
$0.016
Dernière synchronisation: 2024-03-11
Capitalisation boursière
$3.27M
Changement (1 jour)
-5.33%
Changement (1 an)
0.00%
Pays
US
Échange Invitae Corporation (NVTA)

Catégorie

Ratio P/B pour Invitae Corporation (NVTA)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Invitae Corporation, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Invitae Corporation de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US